• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于C反应蛋白的算法预测脊柱关节炎患者的功能残疾:一项为期3年的前瞻性研究。

Predicting functional disability in patients with spondyloarthritis using a CRP-based algorithm: A 3-year prospective study.

作者信息

Catan Liliana, Boariu Marius, Amaricai Elena, Popa Daniel, Puenea George, Drăgoi Mihai, Stratul Ștefan, Drăgoi Răzvan Gabriel

机构信息

Department of Balneology, Medical Rehabilitation and Rheumatology, 'Victor Babes' University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Department of Endodontics, 'Victor Babes' University of Medicine and Pharmacy, 300041 Timisoara, Romania.

出版信息

Exp Ther Med. 2021 Jan;21(1):89. doi: 10.3892/etm.2020.9521. Epub 2020 Nov 26.

DOI:10.3892/etm.2020.9521
PMID:33363600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7725018/
Abstract

This prospective study explored the link between values of C-reactive protein (CRP) in patients with SpA (ankylosing spondylitis, psoriatic arthritis, reactive arthritis, or arthritis-related inflammatory bowel disease) and functional disability in order to derive an algorithm that may predict functional disability based on disease activity. Patients diagnosed with Spa were classified into five groups based on the type of therapy and they were followed up for 3 years. Group 1: Symptomatic medication alone; Group 2: Disease-modifying antirheumatic drugs (DMARDs); Group 3: DMARDs and 30 rehabilitation sessions twice a year; Group 4: Group 3 therapy and biologic anti-tumor necrosis factor-alpha (anti-TNF-α) drugs; and Group 5: Group 4 therapy and, in addition, a daily home-adapted kinesiotherapy program. CRP, modified Health Assessment Questionnaire (mHAQ-S), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and T-score of the patients were recorded. Correlation and multivariate regression analyses were conducted using demographic data, CRP, and mHAQ-S scores to derive the CRP-mHAQ-S correlation algorithm. Statistical analysis included the chi-square, Mann-Whitney, and multiple regression tests and repeated measures analysis of variance. A total of 144 patients were enrolled, all of whom completed the study. The best predictive model (P<0.001) provided the algorithm mHAQ-S=17.14+0.12xCRP-0.24xCRP-0.15xCRP (CRP, CRP, and CRP correspond to CRP levels at baseline, 12, and 36 months, respectively, and mHAQ-S to mHAQ-S score at 36 months). This derived algorithm based on objective CRP assessment may have implications in the prediction of functional disability evolution in patients with SpA.

摘要

这项前瞻性研究探讨了脊柱关节炎(SpA,包括强直性脊柱炎、银屑病关节炎、反应性关节炎或与关节炎相关的炎症性肠病)患者的C反应蛋白(CRP)值与功能残疾之间的联系,以便得出一种可根据疾病活动预测功能残疾的算法。被诊断为SpA的患者根据治疗类型分为五组,并随访3年。第1组:仅使用对症药物;第2组:改善病情抗风湿药(DMARDs);第3组:DMARDs且每年进行30次康复治疗;第4组:第3组治疗加生物抗肿瘤坏死因子-α(抗TNF-α)药物;第5组:第4组治疗,此外还有每日家庭适应性运动疗法计划。记录患者的CRP、改良健康评估问卷(mHAQ-S)、巴斯强直性脊柱炎疾病活动指数(BASDAI)和T评分。使用人口统计学数据、CRP和mHAQ-S评分进行相关性和多变量回归分析,以得出CRP-mHAQ-S相关算法。统计分析包括卡方检验、曼-惠特尼检验、多元回归检验和重复测量方差分析。共纳入144例患者,所有患者均完成研究。最佳预测模型(P<0.001)得出算法mHAQ-S=17.14+0.12xCRP-0.24xCRP-0.15xCRP(CRP、CRP和CRP分别对应基线、12个月和36个月时的CRP水平,mHAQ-S对应36个月时的mHAQ-S评分)。这种基于客观CRP评估得出的算法可能对预测SpA患者功能残疾的演变具有重要意义。

相似文献

1
Predicting functional disability in patients with spondyloarthritis using a CRP-based algorithm: A 3-year prospective study.使用基于C反应蛋白的算法预测脊柱关节炎患者的功能残疾:一项为期3年的前瞻性研究。
Exp Ther Med. 2021 Jan;21(1):89. doi: 10.3892/etm.2020.9521. Epub 2020 Nov 26.
2
Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.简要报告:未经肿瘤坏死因子阻滞剂治疗的早期非放射性轴性脊柱关节炎和强直性脊柱炎患者的两年临床病程:来自德国脊柱关节炎起始队列的结果。
Arthritis Rheumatol. 2015 Sep;67(9):2369-75. doi: 10.1002/art.39225.
3
Disability measured by the modified health assessment questionnaire in early rheumatoid arthritis: prognostic factors after two years of follow-up.采用改良健康评估问卷对早期类风湿关节炎患者的残疾情况进行评估:两年随访后的预后因素。
Clin Exp Rheumatol. 2009 Mar-Apr;27(2):284-91.
4
Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.脊柱关节炎中的纤维肌痛:对临床实践中疾病活动度评估的影响
J Rheumatol. 2016 Nov;43(11):2056-2063. doi: 10.3899/jrheum.160104. Epub 2016 Sep 15.
5
Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.新加坡轴向型脊柱关节炎(axSpA)患者中,含C反应蛋白的强直性脊柱炎疾病活动评分(ASDAS-CRP)和巴斯强直性脊柱炎疾病活动指数(BASDAI)的有效性和可靠性。
Int J Rheum Dis. 2019 Dec;22(12):2206-2212. doi: 10.1111/1756-185X.13735. Epub 2019 Nov 13.
6
Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis.类风湿关节炎患者在接受英夫利昔单抗治疗前后健康评估问卷残疾指数(HAQ-DI)与改良 HAQ(mHAQ)评分的差异。
Mod Rheumatol. 2010 Aug;20(4):337-42. doi: 10.1007/s10165-010-0284-8. Epub 2010 Mar 13.
7
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.肿瘤坏死因子α抑制剂在影像学和非影像学轴向脊柱关节炎中的应用:一项大型观察性队列研究结果
Arthritis Rheum. 2013 Dec;65(12):3096-106. doi: 10.1002/art.38140.
8
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.一线肿瘤坏死因子抑制剂在影像学和非影像学轴向脊柱关节炎中的不同药物生存:一项多中心回顾性调查。
Clin Exp Rheumatol. 2019 Sep-Oct;37(5):762-767. Epub 2019 Apr 16.
9
Drug Levels and Antibodies Against TNF-blockers in Spondyloarthritis and Rheumatoid Arthritis are Associated with the Activity but they do Not Predict it.脊柱关节炎和类风湿关节炎中药物水平及抗肿瘤坏死因子阻滞剂抗体与疾病活动相关,但不能预测疾病活动。
Curr Rheumatol Rev. 2019;15(4):329-335. doi: 10.2174/1573397115666190708113601.
10
Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis.分泌型免疫球蛋白A水平升高与反应性关节炎和未分化脊柱关节炎患者疾病活动指数较低相关。
Front Immunol. 2017 Apr 27;8:476. doi: 10.3389/fimmu.2017.00476. eCollection 2017.

本文引用的文献

1
Optimisation of rheumatology assessments - the actual situation in axial spondyloarthritis including ankylosing spondylitis.风湿病评估的优化——包括强直性脊柱炎在内的轴向型脊柱关节炎的实际情况。
Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-96-104. Epub 2014 Oct 30.
2
Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review.强直性脊柱炎患者的健康相关生活质量:一项综合综述。
Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):857-72. doi: 10.1586/14737167.2014.957679. Epub 2014 Sep 5.
3
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study.影响银屑病关节炎患者工作能力丧失的因素:来自一项大型英国多中心研究的初步结果。
Rheumatology (Oxford). 2015 Jan;54(1):157-62. doi: 10.1093/rheumatology/keu264. Epub 2014 Aug 13.
4
Proteomics focusing on immune markers in psoriatic arthritis.聚焦银屑病关节炎免疫标志物的蛋白质组学。
Biomark Med. 2015;9(6):513-28. doi: 10.2217/BMM.14.76. Epub 2014 Jul 18.
5
Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world.银屑病关节炎的疾病活动度:现实世界中六种综合指数的鉴别能力与结构效度比较
Biomed Res Int. 2014;2014:528105. doi: 10.1155/2014/528105. Epub 2014 May 20.
6
Study of bone mineral density in patients with ankylosing spondylitis.强直性脊柱炎患者骨密度的研究。
J Clin Diagn Res. 2013 Dec;7(12):2832-5. doi: 10.7860/JCDR/2013/6779.3770. Epub 2013 Dec 15.
7
Exercise therapy for spondyloarthritis: a systematic review.脊柱关节炎的运动疗法:一项系统评价
Rheumatol Int. 2014 Jul;34(7):887-902. doi: 10.1007/s00296-014-2965-7. Epub 2014 Feb 19.
8
Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necrosis factor-blockers.在接受肿瘤坏死因子阻滞剂治疗的短病程而非长病程的轴性脊柱关节炎患者中,炎症客观体征与主观体征的变化之间存在良好的相关性。
Arthritis Res Ther. 2014 Jan 30;16(1):R35. doi: 10.1186/ar4464.
9
Epidemiology of spondyloarthritis: a review.脊柱关节炎的流行病学:综述。
Curr Rheumatol Rep. 2013 Sep;15(9):351. doi: 10.1007/s11926-013-0351-1.
10
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.治疗脊柱关节炎,包括强直性脊柱炎和银屑病关节炎,以靶向治疗为目标:国际工作组的建议。
Ann Rheum Dis. 2014 Jan;73(1):6-16. doi: 10.1136/annrheumdis-2013-203419. Epub 2013 Jun 8.